Article Versions Notes

Mishra A, de Bourg M, Mohamed RS, Hye Khan MA, Weldemichael T, Johann DJ Jr., Goorani S, Bommagani S, Jones DE, Vik A, et al. EET-Based Therapeutics Mitigate Sorafenib-Associated Glomerular Cell Damage. Biomolecules. 2025; 15(9):1324. https://doi.org/10.3390/biom15091324

Mishra, Abhishek, Marcus de Bourg, Rawand S. Mohamed, Md Abdul Hye Khan, Tsigereda Weldemichael, Donald J. Johann, Jr., Samaneh Goorani, Shobanbabu Bommagani, Darin E. Jones, Anders Vik, and et al. 2025. "EET-Based Therapeutics Mitigate Sorafenib-Associated Glomerular Cell Damage" Biomolecules 15, no. 9: 1324. https://doi.org/10.3390/biom15091324

Mishra, A., de Bourg, M., Mohamed, R. S., Hye Khan, M. A., Weldemichael, T., Johann, D. J., Jr., Goorani, S., Bommagani, S., Jones, D. E., Vik, A., & Imig, J. D. (2025). EET-Based Therapeutics Mitigate Sorafenib-Associated Glomerular Cell Damage. Biomolecules, 15(9), 1324. https://doi.org/10.3390/biom15091324